Once-weekly subcutaneous injection at the therapeutic dose of 2.4mgsimple to incorporate into any routine
The compound is one of the most-studied peptides in preclinical regenerative-research literature, with more than 100 published animal studies covering gastric and intestinal cytoprotection, tendon and ligament repair, angiogenic pathway activity, and central nervous system models
When administered, the peptide binds to the GHS receptors in the pituitary gland, triggering the release of GH to help reduce visible aging , enhance recovery, and increase muscle mass
Gut surgery, pancreatic insufficiency, small intestinal bacterial overgrowth (SIBO), parasite infections, and certain autoimmune disorders are considered additional risk factors
Copper peptidesespecially GHK-Cusupport these processes when used thoughtfully and appropriately
For illustrative purposes only and not indicative of the Fund